2016. APLAR Congress – Secukinumab for Psoriatic Arthritis: Comparative Effectiveness Results versus Etanercept Up To 24 Weeks Using a Matching-Adjusted Indirect Comparison

McInnes IB, Nash P, Mease P, Thom H, Hunger M, Gandhi K, Mpofu S, Jugl S. Secukinumab for Psoriatic Arthritis: Comparative Effectiveness Results versus Etanercept Up To 24 Weeks Using a Matching-Adjusted Indirect Comparison. Presented at: 8th Asia Pacific League of Associations for Rheumatology Congress (APLAR). September 26-29, 2016; Shangai, China.